Shop

Faslodex Injection Imported (Fulvestrant) is a prescription medication used to treat hormone receptor-positive (HR+) advanced or metastatic breast cancer in postmenopausal women. It belongs to a class of drugs known as selective estrogen receptor degraders (SERDs), which work by blocking and degrading estrogen receptors on cancer cells, slowing their growth and spread.

Each pre-filled syringe of Faslodex contains 250mg of Fulvestrant, administered via intramuscular injection by a healthcare professional. Doctors often prescribe Faslodex as a monotherapy or in combination with other targeted therapies for patients who have experienced disease progression after endocrine therapy.

Faslodex provides an effective alternative to tamoxifen and aromatase inhibitors, especially in cases where tumors become resistant to first-line hormone treatments. Treatment schedules usually involve two injections on the first day, followed by additional doses every two weeks for the first month, and then monthly thereafter.

Patients should not attempt self-administration, as the injection requires deep intramuscular delivery in a clinical setting. Regular monitoring of liver function and treatment response is essential during therapy.

Store Faslodex syringes in a refrigerator at 2°C to 8°C. Do not freeze or shake the syringe. Keep the product away from children and direct light.